| Literature DB >> 31441938 |
Chenlu Gao1, Nikita Y Chapagain1, Michael K Scullin1.
Abstract
Importance: In the United States, 16 million family caregivers provide long-term care for patients with dementia. Although one's physical, mental, and cognitive health depends on sleep, many caregivers experience chronic stress, and stress is typically associated with worse sleep quantity and quality. Objective: To quantify the extent, nature, and treatability of sleep problems in dementia caregivers. Data Sources: PubMed and Scopus databases were systematically searched for articles published through June 2018 using the following keywords: caregiver or spouse or caretaker AND sleep or circadian AND dementia or Alzheimer. Backward citation tracking was performed, and corresponding authors were contacted for additional data to conduct meta-analyses and pooled analyses. Study Selection: Two reviewers independently screened 805 studies to identify those that reported sleep duration or sleep quality in caregivers of patients with dementia. Data Extraction and Synthesis: Following the PRISMA guidelines, 2 reviewers independently extracted data from all studies and conducted National Heart, Lung, and Blood Institute study quality assessments. Meta-analyses with random-effects models were performed to evaluate sleep duration, sleep quality, and sleep interventions in dementia caregivers. Main Outcomes and Measures: Sleep quality and total sleep time were measured by polysomnography, actigraphy, and self-report.Entities:
Mesh:
Year: 2019 PMID: 31441938 PMCID: PMC6714015 DOI: 10.1001/jamanetworkopen.2019.9891
Source DB: PubMed Journal: JAMA Netw Open ISSN: 2574-3805
Figure 1. PRISMA Diagram of the Study Selection Process
PRISMA indicates Preferred Reporting Items for Systematic Reviews and Meta-analyses.
Studies That Reported Total Sleep Time (19 Studies) and Sleep Quality (29 Studies) Separated by Caregiver and Control Data
| Source | No. | Total Sleep Time Measure | Sleep Quality Measure | Included in Meta-analysis of Total Sleep Time | Included in Meta-analysis of Sleep Quality | |
|---|---|---|---|---|---|---|
| Caregivers | Controls | |||||
| Wilcox and King,[ | 90 | NA | PSQI | PSQI | No | No |
| King et al,[ | 94 | NA | PSQI | PSQI | No | No |
| Caswell et al,[ | 44 | 66 | NA | SPQ | No | Yes |
| Ancoli-Israel et al,[ | 63 | NA | NA | PSQI | No | No |
| McCurry et al,[ | 36 | NA | Actigraphy | PSQI | No | No |
| McKibbin et al,[ | 73 | 40 | PSG | PSQI | Yes | Yes |
| Vitaliano et al,[ | 96 | 95 | NA | PSDQ | No | Yes |
| Brummett et al,[ | 175 | 169 | NA | PSQI | No | Yes |
| Mausbach et al,[ | 40 | NA | PSG | NA | No | No |
| Willette-Murphy et al,[ | 37 | 37 | Sleep diary | MDSD | Yes | Yes |
| Adachi et al,[ | 42 | NA | NA | PSQI | No | No |
| Lee et al,[ | 39 | NA | Actigraphy | PSQI | No | No |
| Beaudreau et al,[ | 60 | NA | Actigraphy | NA | No | No |
| Korn et al,[ | 42 | NA | NA | PSQI | No | No |
| Elliot et al,[ | 495 | NA | NA | Self-report | No | No |
| Simpson and Carter,[ | 10 | NA | Actigraphy | PSQI | No | No |
| Fonareva et al,[ | 20 | 20 | PSG | PSQI | Yes | Yes |
| Hirano et al,[ | 31 | NA | NA | Self-report | No | No |
| Kiecolt-Glaser et al,[ | 58 | 74 | PSQI | PSQI | Yes | Yes |
| Oken et al,[ | 31 | 25 | NA | PSQI | No | Yes |
| Cupidi et al,[ | 40 | 150 | NA | PSQI | No | Yes |
| Simpson and Carter,[ | 15 | NA | NA | PSQI | No | No |
| Merrilees et al,[ | 22 | NA | Actigraphy | PSQI | No | No |
| von Känel et al,[ | 126 | NA | Actigraphy | PSQI | No | No |
| Figueiro et al,[ | 34 | NA | Actigraphy | PSQI | No | No |
| Sakurai et al,[ | 20 | 20 | Actigraphy | PSQI | Yes | Yes |
| Simpson and Carter,[ | 80 | NA | PSQI | PSQI | No | No |
| Sloane et al,[ | 17 | NA | NA | PSQI | No | No |
| Lathan et al,[ | 527 | NA | Self-report | NA | No | No |
| Leggett et al,[ | 158 | NA | Self-report | NA | No | No |
| Wang et al,[ | 72 | NA | NA | PSQI | No | No |
| Gibson et al,[ | 15 | NA | Actigraphy | PSQI | No | No |
| Liu et al,[ | 492 | NA | NA | PSQI | No | No |
Abbreviations: MDSD, Morin Daily Sleep Diary; NA, not applicable; PSDQ, Pittsburgh Sleep Disorders Questionnaire; PSG, polysomnography; PSQI, Pittsburgh Sleep Quality Index; SPQ, Sleep Problems Questionnaire.
Figure 2. Forest Plots for Total Sleep Time,[20,24,31,33,39] Sleep Quality,[6,17,20,21,22,24,31,33,34,39] and Sleep-Related Intervention[16,18,26,28,29,32,41,54,55] Outcomes
A-C, Shown are the mean difference in total sleep time between caregiver (n = 208) and control (n = 191) participants (A), the mean difference in sleep quality between caregiver (n = 594) and control (n = 696) participants (B), and the mean difference in sleep quality between the intervention (n = 469) and control (n = 434) conditions (C). Each square and the line crossing the square represent the standardized effect size and its 95% CI. The size of each square represents the weight of the study. The diamonds represent the mean standardized effect sizes (with their 95% CIs). MDSD indicates Morin Daily Sleep Diary; PSG, polysomnography; PSQI, Pittsburgh Sleep Quality Index; and SPQ, Sleep Problems Questionnaire.
Thirteen Intervention Studies in Caregivers
| Source | No. of Caregivers | Intervention | Mean (SD) | Included in the Meta-analysis of Intervention | Randomization | ITT Analysis | |||
|---|---|---|---|---|---|---|---|---|---|
| Total Sleep Time, h | PSQI | ||||||||
| Intervention | Control | Intervention | Control | ||||||
| McCurry et al,[ | 36 | Behavioral intervention | 6.4 (0.9) | 6.1 (1.0) | 7.8 (3.3) | 10.6 (4.4) | Yes | Yes | No |
| King et al,[ | 94 | Moderate-intensity exercise | 6.69 (1.16) | 6.66 (1.12) | 7.14 (3.40) | 7.51 (3.67) | Yes | Yes | No |
| Ancoli-Israel et al,[ | 63 | Cholinesterase inhibitors (galantamine hydrobromide/donepezil hydrochloride) for care recipients | NA | NA | −0.97 (2.96) | NA | Yes | Yes | Yes |
| McCurry et al,[ | 36 | Sleep hygiene, daily walking, light exposure | NA | 7.0 (1.0) | NA | 8.6 (3.4) | No | Yes | Yes |
| Lee et al,[ | 39 | Institutional respite care | 6.88 (0.85) | 6.72 (0.81) | NA | NA | Yes | No | No |
| Korn et al,[ | 42 | Polarity therapy | NA | NA | −3.1 (3.9) | −1.4 (3.2) | Yes | Yes | Yes |
| Rose et al,[ | 38 | Cranial electrical stimulation | NA | NA | 7.8 | 8.2 | Yes | Yes | No |
| Elliott et al,[ | 495 | Resources for Enhancing Alzheimer’s Caregiver Health (REACH) II trial | NA | NA | NA | NA | Yes | Yes | No |
| Simpson and Carter,[ | 10 | Behavioral intervention | 6.88 (1.43) | 7.18 (1.19) | 5.20 (3.91) | 7.80 (4.98) | No | No | No |
| Hirano et al,[ | 31 | Moderate-intensity exercise | NA | NA | NA | NA | Yes | Yes | No |
| Figueiro et al,[ | 34 | Tailored lighting | 5.71 (0.94) | 5.89 (1.21) | 6.22 (2.93) | 6.70 (2.13) | No | No | No |
| Sloane et al,[ | 17 | Blue-white light therapy | NA | NA | 3.7 | 5.4 | Yes | No | No |
| Gibson et al,[ | 15 | Bright light therapy, exercise, sleep hygiene education | NA | 7.38 (0.82) | NA | 6.60 (2.80) | No | No | No |
Abbreviations: ITT, intent-to-treat; NA, not available or used a different sleep quality measure; PSQI, Pittsburgh Sleep Quality Index.
Change score from baseline.
Within-subject intervention studies were only included in the meta-analysis if means and SDs of change scores were available.
Figure 3. Study Quality Assessment Summary
Shown are the strengths and weaknesses of study quality in the sleep and caregiver literature, as defined by National Heart, Lung, and Blood Institute study quality assessments.